• 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 14003-96-4 br ACCEPTED MANUSCRIPT br staffing of


    staffing of intensive care units, availability of diagnostic technology, access to clinical trials, and more aggressive post-resection cancer surveillance.
    The use of neoadjuvant therapy followed by esophagectomy in patients with ESCC is associated with improved long-term survival after adjusting for patient, facility, and tumor related characteristics. Patients treated at high-volume facilities were more likely to receive neoadjuvant therapy and there was a significant inverse relationship between annual surgical volume and long-term survival. These findings suggest that regionalizing treatment of patients with ESCC to high-volume facilities may improve survival outcomes.
    2. Lightdale CJ. Esophageal cancer. American College of Gastroenterology. Am J Gastroenterol 1999;94(1):20-29
    6. Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: Systematic review and meta-analysis 2000-2011. J Gastrointest Surg 2012;16(5):1055-1063
    8. Tepper J, Krasna MJ, Niedzwiecki D et al. Phase iii trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: Calgb 9781. J Clin Oncol 2008;26(7):1086-1092
    9. Nygaard K, Hagen S, Hansen HS et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer. World Journal of Surgery 1992;16(6):1104-1109 10. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337(3):161-167
    11. Burmeister BH, Smithers BM, Gebski V et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase iii trial. Lancet Oncol 2005;6(9):659-668
    12. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19(2):305-313 13. Le Prise E, Etienne PL, Meunier B et al. A randomized study of chemotherapy, 14003-96-4 therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73(7):1779-1784
    14. Pasquali S, Yim G, Vohra RS et al. Survival after neoadjuvant and adjuvant treatments
    compared to surgery alone for resectable esophageal carcinoma: A network meta-analysis. Annals of Surgery 2017;265(3):481-491
    18. Pal N, Axisa B, Yusof S et al. Volume and outcome for major upper gi surgery in England. Journal of Gastrointestinal Surgery 2008;12(2):353-357 19. Wouters MW, Wijnhoven BP, Karim-Kos HE et al. High-volume versus low-volume for
    esophageal resections for cancer: The essential role of case-mix adjustments based on clinical data. Annals of Surgical Oncology 2008;15(1):80-87
    20. Hannan EL, Kilburn H, Jr., Bernard H, O'Donnell JF, Lukacik G, Shields EP. Coronary artery bypass surgery: The relationship between inhospital mortality rate and surgical volume after controlling for clinical risk factors. Med Care 1991;29(11):1094-1107
    21. Hannan EL, Racz M, Kavey RE, Quaegebeur JM, Williams R. Pediatric cardiac surgery: The effect of hospital and surgeon volume on in-hospital mortality. Pediatrics 1998;101(6):963-969 22. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002;131(1):6-15
    23. Gooiker GA, van Gijn W, Wouters MW, Post PN, van de Velde CJ, Tollenaar RA. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg 2011;98(4):485-494 24. Gordon TA, Bowman HM, Bass EB et al. Complex gastrointestinal surgery: Impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999;189(1):46-56
    25. Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999;134(1):30-35
    26. Lin HC, Lin CC. Surgeon volume is dominance hierarchy predictive of 5-year survival in patients with hepatocellular carcinoma after resection: A population-based study. Journal of Gastrointestinal Surgery: 2009;13(12):2284-2291 27. Speicher PJ, Englum BR, Ganapathi AM et al. Traveling to a high- volume center is associated with improved survival for patients with esophageal cancer. Annals of Surgery 2017;265(4):743-749
    Table 1: Tumor characteristics, perioperative, and survival outcomes